Stockreport

Praxis Precision Medicines, Inc. (PRAX) a Strong Buy, Per Wall Street Consensus [Yahoo! Finance]

Praxis Precision Medicines, Inc.  (PRAX) 
PDF On January 12, Wedbush analyst Laura Chico lifted the price target on the stock to $95 from $83, citing the company's recent public offering as the basis for the adjust [Read more]